PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Losartan potassium with diuretic
Presentation Product Chemical substance Chapter Items dispensed
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets
0205052P0AAAAAA
Losartan potassium/hydchlorothiazide Losartan potassium with diuretic Cardiovascular System 14,855
Losartan 100mg / Hydrochlorothiazide 25mg tablets
0205052P0AAABAB
Losartan potassium/hydchlorothiazide Losartan potassium with diuretic Cardiovascular System 14,717
Losartan 100mg / Hydrochlorothiazide 12.5mg tablets
0205052P0AAACAC
Losartan potassium/hydchlorothiazide Losartan potassium with diuretic Cardiovascular System 8,287
Cozaar-Comp 50mg/12.5mg tablets
0205052P0BBAAAA
Cozaar-Comp Losartan potassium with diuretic Cardiovascular System 382
Cozaar-Comp 100mg/25mg tablets
0205052P0BBABAB
Cozaar-Comp Losartan potassium with diuretic Cardiovascular System 300
Cozaar-Comp 100mg/12.5mg tablets
0205052P0BBACAC
Cozaar-Comp Losartan potassium with diuretic Cardiovascular System 256

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.